NLS Pharmaceutics Ltd. Announces Expected Implementation of 1-for-40 Reverse Share Split
Express News | Trading Halt: Halt Status Updated at 7:30:00 AM ET: Quotation Resumption: News and Resumption Times
Express News | Trading Halt: Halted at 6:56:51 A.m. ET - Trading Halt: Halt News Pending
NLS Pharmaceutics Looks to Raise $0.79M via Securities Offering
NLS Pharmaceutics Announces Publication Of New Patent Application For Next-Gen Dual Non-Sulfonamide Orexin Receptor Agonists With The World Intellectual Property Organization
6-K: Report of foreign private issuer (related to financial reporting)